Newsroom | Top Stories | Abbott U.S.
Jun 10, 2024 · Innovating for a Healthier, Sustainable Future. Abbott's Global Sustainability Report shares how we're focused on helping more people, now and in the years ahead. SEE MORE. An overview of our business, including our financial profile and public honors.
Abbott MediaRoom - Press Releases
Oct 10, 2024 · Abbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores. Aug 21, 2024.
Abbott shares rise after securing first win in premature infant …
Nov 1 (Reuters) - Abbott Laboratories (ABT.N) shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature ...
Abbott Receives U.S. FDA Clearance for Two New Over-the …
ABBOTT PARK, Ill., June 10, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used b...
Abbott Reports Fourth-Quarter and Full-Year 2023 ... - Abbott …
ABBOTT PARK, Ill., Jan. 24, 2024 /PRNewswire/ -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1 .
Abbott shares rise after securing first win in premature infant …
Nov 1, 2024 · In This Article: (Reuters) - Abbott Laboratories (ABT) shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their ...
Abbott’s Q4 Earnings Sustain Momentum Into 2024
Jan 24, 2024 · Sales for the fourth quarter of 2023 reached $10.2 billion, an 11.0% organic increase, excluding COVID-19 testing-related revenue, driven by Medical Devices (up 15.4% organic; 17.5% reported) and Nutrition (up 13.9% organic; 12.2% reported).
Abbott Q4 Earnings: Continued Resiliency | Abbott Newsroom
Jan 25, 2023 · Abbott issued full-year guidance for 2023 adjusted diluted EPS from continuing operations of $4.30 to $4.50. 3 These are the key fourth-quarter highlights: Sales of FreeStyle Libre systems exceeded $1 billion with U.S. sales growing more than 40%.
Abbott Bumps Up Forecast as Device Sales Boost Quarter - Bloomberg.com
Jul 18, 2024 · Abbott Laboratories nudged up its full-year profit guidance as strong growth in its medical-devices segment helped quarterly results beat estimates. Adjusted earnings for 2024 will be from $4.61...
Abbott Laboratories Shares Rise After Baby-Formula Verdict
Oct 31, 2024 · Shares of Abbott, which makes the Similac formula, rose 5.4% to $119.50 in after-hours trading Thursday. The stock ended the regular session having edged lower by 0.9% to $113.37, and is up 3% ...
- Some results have been removed